0.3799

5.03% -0.0201

AIM ImmunoTech Inc (AIM)

Overview News Price History Discussions Forecast Stock Split

AIM ImmunoTech Inc stock is traded at $0.3799, with a volume of 3.05M. It is down -5.03% in the last 24 hours and down -6.89% over the past month. AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen, a drug of macromolecular ribonucleic acid molecule for the treatment of chronic fatigue syndrome. It is also developing Ampligen for the treatment of Hepatitis B and HIV, as well as patients with renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, urothelial, prostate, and pancreatic cancer. AIM ImmunoTech Inc. has agreements with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd. for the evaluation and discussion of business relationships concerning a COVID-19 therapeutic and vaccine. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

Previous Close:

$0.40

Open:

$0.3953

24h Volume:

3.05M

Relative Volume:

0.11

Market Cap:

$10.24M

Revenue:

$94,000

Net Income/Loss:

$-13.28M

P/E Ratio:

-0.0521

EPS:

-7.2965

Net Cash Flow:

$-11.67M

1W Performance:

-17.40%

1M Performance:

-6.89%

6M Performance:

-72.05%

1Y Performance:

-95.42%

1-Day Range:

$0.3623

$0.40

1-Week Range:

$0.3623

$0.4433

52-Week Range:

$0.21

$20.33

AIM ImmunoTech Inc Stock (AIM) Company Profile

Name

AIM ImmunoTech Inc

Sector

Healthcare (1104)

Industry

Biotechnology (617)

Phone

352 448 7797

Address

2117 SW Highway 484, Ocala, FL

Employee

Twitter

@AIMImmuno

Next Earnings Date

2026-05-21

Latest SEC Filings

AIM's Discussions on Twitter

Compare AIM vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AIM AIM ImmunoTech Inc	0.3799	10.24M	94,000	-13.28M	-11.67M	-7.2965
VRTX Vertex Pharmaceuticals Inc	451.63	114.63B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	609.94	63.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.72	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	278.09	37.13B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	162.99	34.65B	742.00K	-1.37B	-1.07B	-7.0731

AIM ImmunoTech Inc Stock (AIM) Latest News

Jun 18, 2026

AIM ImmunoTech (NYSE American: AIM) resale of 31.3M warrant‑related shares - Stock Titan

Jun 18, 2026

AIM ImmunoTech clears final dose milestone in pancreatic cancer trial - Stock Titan

Jun 18, 2026

AIM ImmunoTech Achieves Clinical Milestone as Final Subject - GlobeNewswire

Jun 18, 2026

Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders - TradingView

Jun 18, 2026

AIM ImmunoTech (NYSE: AIM) registers 13.1M shares for resale in June deals - Stock Titan

Jun 18, 2026